Yale Catriona
Akero Therapeutics, Inc. · Chief Development Officer
Yale Catriona is listed in filings as Chief Development Officer at Akero Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 9, 2025, including sale activity. Recent filings connect the profile to Akero Therapeutics, Inc. (AKRO). The current snapshot covers public activity from Feb 21, 2025 to Dec 9, 2025. Reported amounts are shown as $3.6M to $2.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $28k659 shares | SellSep 11, 2025 | $43.02 | $54.65 |